Training activity information
Details
Analyse and interpret genomic results from circulating tumour DNA (ctDNA) testing in lung cancer
Type
Developmental training activity (DTA)
Evidence requirements
Evidence the activity has been undertaken by the trainee​.
Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.
An action plan to implement learning and/or to address skills or knowledge gaps identified.
Considerations
Considerations are suggestions about what may be useful for the trainee to think about while undertaking a training activity. They should not be considered as a mandatory checklist. Trainees should not be expected to demonstrate or provide evidence for each of the considerations listed.
- Acceptance criteria and limitations of samples
- Principles of the testing strategy
- Factors impacting on downstream processes
- IQC and EQA
- Local SOPs
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 2 |
Outcome
Analyse, interpret and prepare interpretive reports of clinically relevant findings for patients with lung, central nervous system (CNS), sarcoma tumours, and somatic and germline variants in ovarian and breast cancer. |
| # 4 |
Outcome
Interpret QC data including bioinformatic and NGS quality metrics in relation to assay performance, EQA and ISO:15189 standards. |
| # 5 |
Outcome
Analyse, interpret and prepare interpretive reports for circulating tumour DNA (ctDNA) testing in lung cancer. |
| # 8 |
Outcome
Practice with relevant specialties for the diagnosis and treatment of cancer patients, and contribute to multidisciplinary team meetings. |